companydata.dkcompanydata.dk

SANDOZ A/S: Financial statements 2025

CVR: 27744532

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

SANDOZ A/S (CVR 27744532) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 2,515,342,000 and a net result of DKK 85,168,000 compared with DKK 48,047,000 the year before. That is a decrease of 0.3% compared with the year before. The profit margin was 3.4%. Equity in the 2025 report amounted to DKK 662,792,000. The solvency ratio was 43.6%. The company had 149 employees in the financial year.

Revenue
DKK 2,515,342,000
Gross Profit
DKK 260,170,000
Profit/Loss
DKK 85,168,000
Equity
DKK 662,792,000
Total Assets
DKK 1,521,347,000
Employees
149

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20252.5 mia.260.2 mio.85.2 mio.662.8 mio.149
20242.5 mia.240.6 mio.48 mio.577.6 mio.106
20232.3 mia.233.6 mio.68.5 mio.529.6 mio.104
20222.2 mia.230.6 mio.42.9 mio.461.1 mio.100
20212 mia.220 mio.58 mio.418.1 mio.108

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SANDOZ A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

SANDOZ A/S wins public contractDec 19, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.1480.b" issued by Amgros I/S worth 1,078,800,000 DKK.

SANDOZ A/S wins public contractNov 26, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.607.a" issued by Amgros I/S worth 60,481,552 DKK.

SANDOZ A/S wins public contractNov 25, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.208.a" issued by Amgros I/S worth 4,129,684 DKK.

SANDOZ A/S wins public contractNov 25, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.1212.a" issued by Amgros I/S worth 44,707,811 DKK.

SANDOZ A/S wins public contractNov 18, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.1559.b" issued by Amgros I/S worth 527,000,000 DKK.

SANDOZ A/S wins public contractNov 14, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.601.a" issued by Amgros I/S worth 331,750,548 DKK.

SANDOZ A/S wins public contractOct 31, 2025

SANDOZ A/S has won the tender "Amgros 2026 2.1302.b" issued by Amgros I/S worth 161,990,275 DKK.

SANDOZ A/S wins public contractOct 31, 2025

SANDOZ A/S has won the tender "Amgros 2026 2.1390.b" issued by Amgros I/S worth 23,945,273 DKK.

SANDOZ A/S wins public contractOct 30, 2025

SANDOZ A/S has won the tender "Amgros 2026 1.615.b" issued by Amgros I/S worth 48,195,968 DKK.

SANDOZ A/S wins public contractOct 27, 2025

SANDOZ A/S has won the tender "Amgros 2026 2.290.b" issued by Amgros I/S worth 88,050,546 DKK.

About SANDOZ A/S

SANDOZ A/S is a Danish company of the type Aktieselskab based in København S, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named DURASCAN MEDICAL PRODUCTS A/S. The management consists of Lawrence Edward Mead. The board consists of Diane Marie DiGangi (chair), Lawrence Edward Mead and Nete Brændgaard. The company is owned by Sandoz AG. The company has 119 employees (2026). In 2025, the company reported revenue of DKK 2,515,342,000 and a net result of DKK 85,168,000 compared with DKK 48,047,000 the year before. Equity in the 2025 report amounted to DKK 662,792,000.

Source: annual report 2025, Danish Business Authority